Nicola Mitwasi

440 citations
15 papers · 225 indexed · h-index 8
Topics
CAR-T cell therapy research (15 papers)Nanowire Synthesis and Applications (8 papers)Immunotherapy and Immune Responses (4 papers)
Partner nations
GermanyHungaryCzechia

In The Last Decade

Nicola Mitwasi

15 papers receiving 223 citations

Peers

Nicola Mitwasi
Comparison fields: 5 of 24
  • Oncology 202
  • Biomedical Engineering 91
  • Immunology 87
  • Molecular Biology 55
  • Genetics 53
Replace Haiyan Chu with:
Haiyan Chu United States
Audrey Fung United States
Christian Flugel Germany
Satoshi Shiina Japan
Shizhen Qiu China
Diana Gumber United States
Roseanna M. Petrovic United Kingdom
Daniela Tantalo Australia
Isabel Leung United States
John Pineda United States
Nicola Mitwasi relative to Haiyan Chu United States Haiyan Chu's profile →
Citations per field
00.5×1.5×
Haiyan Chu · 1×
Citations per year

Countries citing papers authored by Nicola Mitwasi

Since Specialization
Citations

This map shows the geographic impact of Nicola Mitwasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Mitwasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Mitwasi more than expected).

Fields of papers citing papers by Nicola Mitwasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Mitwasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Mitwasi. The network helps show where Nicola Mitwasi may publish in the future.

Co-authorship network of co-authors of Nicola Mitwasi

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Mitwasi. A scholar is included among the top collaborators of Nicola Mitwasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Mitwasi. Nicola Mitwasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 9
3 8
4 6
5 3
6 16
7 4
8 1
9 27
10 18
11 50
12 2
13 5
14 28
15 47

About Nicola Mitwasi

Nicola Mitwasi is a scholar working on Oncology, Immunology and Biomedical Engineering, having authored 15 papers that have together received 225 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Nanowire Synthesis and Applications (8 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (202 citations), Immunology (87 citations) and Biomedical Engineering (91 citations). Nicola Mitwasi has collaborated with scholars based in Germany, Hungary and Czechia. Frequent co-authors include Anja Feldmann, Claudia Arndt, Michael Bachmann, Ralf Bergmann, Alexandra Kegler, Stefanie Koristka, Nicole Berndt, Anja Hoffmann, Liliana R. Loureiro and Jens Pietzsch. Their work appears in journals such as Blood, International Journal of Molecular Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026